NUWE Nuwellis, Inc.


$ 3.35 $ -0.03 (-0.89 %)    

Friday, 17-Oct-2025 14:57:03 EDT
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 3.38
$ 3.31 x 300
$ 3.41 x 3
$ 3.33 - $ 3.39
$ 3.09 - $ 175.98
64,432
na
nm
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 robert-b-scott-resigns-as-cfo-of-nuwellis-john-l-erb-appointed-interim-cfo

https://www.sec.gov/Archives/edgar/data/1506492/000114036125037713/ef20056785_8k.htm

 nuwellis-announces-findings-from-ultra-peds-registry-study-examining-real-world-use-of-aquadex-system-in-children-with-aki-fluid-overload-or-congenital-kidney-failure

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill c...

 nuwellis-secures-us-patent-for-hemolysis-sensor-technology-in-blood-filtration-systems-supporting-pediatric-device-vivian-and-platform-innovation

Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. ...

 nuwellis-signs-loi-to-acquire-rendiatech-advancing-renal-monitoring-capabilities-beyond-ultrafiltration-deal-expected-to-close-in-q4-2025

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal h...

 nuwellis-announces-first-patients-have-been-successfully-treated-with-aquadex-ultrafiltration-therapy-in-a-hospital-based-outpatient-setting

 Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming fluid management, today announced that th...

 nuwellis-shareholders-approve-warrant-exercise-share-increase-from-100m-to-200m-and-reverse-split-at-a-ratio-between-1-for-5-to-1-for-70-to-boost-financial-flexibility

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on fluid management, today announced that stockholders appro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION